The CRISPR patent fight appears to be over, at least for the moment. A ruling by the U.S. Patent Trial and Appeal Board found no “interference” in patents awarded to Feng Zhang at the Broad Institute of MIT and Harvard.
Democracy Dies in Darkness
Broad Institute scientist prevails in epic patent fight over CRISPR
and
February 15, 2017 at 2:40 p.m. EST